Pathkey.AI Ltd
Price Chart
OHLC · volume · moving averages
Market Statistics
Today's trading range
Valuation
Fundamental multiples
Trading Activity
Volume & order book
Performance
Returns across timeframes
Technical Indicators
Momentum & moving averages
— From the desk
Latest News
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]